Stifel Financial
BLRX icon

Stifel Financial’s BioLineRX BLRX Stock Holding History

Stifel Financial’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$47.1K Buy
+20,041
New +$55.2K ﹤0.01% 3699

Other funds holding BLRX

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Nemes Rush Group
Nemes Rush Group Novi, Michigan $1.22B AUM 25.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Stifel Financial's BLRX Position: Q3 2026 in Review

Stifel Financial opened a new position in BioLineRX (BLRX) in Q3 2026: 20,041 shares worth $47.1K. The stake represents ﹤0.01% of the portfolio and ranks #3699 among its holdings.

9 funds tracked by Wall St. Rank hold BLRX as of Q3 2026.

  • Stifel Financial held 20,041 shares of BioLineRX worth $47.1K as of Q3 2026.
  • BioLineRX was a new Stifel Financial position in Q3 2026.
  • BioLineRX made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #3699 holding.
  • 9 funds tracked by Wall St. Rank held BioLineRX as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.